Open AccessRifaximin as a rare cause of rhabdomyolysis in cirrhosis
Author(s) -
Rezigh Alec B.,
Armenia Erin,
Li Ting,
Soesilo Irene
Publication year - 2018
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1583
Subject(s) - rifaximin , medicine , rhabdomyolysis , cirrhosis , etiology , hepatic encephalopathy , intensive care medicine , encephalopathy , gastroenterology , antibiotics , microbiology and biotechnology , biology
Key Clinical Message Rifaximin has only been rarely reported to cause rhabdomyolysis. When physical and nonphysical etiologies have been excluded, thorough review of the patient’s medication list is necessary. In cirrhotics, the potential harm of rifaximin in treatment or prophylaxis of hepatic encephalopathy should be recognized.